Mitochondrial dysfunction in insulin insensitivity: Implication of mitochondrial role in type 2 diabetes

Annals of the New York Academy of Sciences

Volumn 1201, Issue , 2010, Pages 157-165

  Wang, Chih Hao ^a   Wang, Ching Chu ^a   Wei, Yau Huei ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

insulin insensitivity; mitochondrial dysfunction; persistent organic pollutants; type 2 diabetes

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ACETYLCYSTEINE; ADIPONECTIN; ALPHA TOCOPHEROL; ASCORBIC ACID; ATRAZINE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; INSULIN; INTERLEUKIN 6; LEPTIN; PIOGLITAZONE; RESISTIN; RESVERATROL; ROSIGLITAZONE; THIOCTIC ACID; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; ANTIOXIDANT; ORGANIC COMPOUND;

ADIPOCYTE; CONFERENCE PAPER; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MATERNALLY INHERITED DIABETES AND DEAFNESS; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; POLLUTANT; PROADIPOCYTE; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; ANIMAL; BIOLOGICAL MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; RAT; REVIEW;

ADIPONECTIN; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL POLLUTANTS; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MICE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; ORGANIC CHEMICALS; OXIDATIVE PHOSPHORYLATION; RATS;

EID: 77955293072     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05625.x     Document Type: Conference Paper

References (40)

1. Petersen, K.F. & G.I. Shulman. 2006. Etiology of insulin resistance. Am. J. Med. 119: S10-S16.
2. Korc,M. 2004.Update on diabetesmellitus. Dis.Markers 20: 161-165.
3. Despres, J.P. & I. Lemieux. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
4. Wallace, D.C. 2005. Amitochondrial paradigmofmetabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39: 359-407.
5. VanDenOuweland, J.M.,H.H. Lemkes,W.Ruitenbeek, et al. 1992.Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetesmellitus and deafness. Nat. Genet. 1: 368-371.
6. Liang, P., V. Hughes & N.K. Fukagawa. 1997. Increased prevalence of mitochondrial DNA deletions in skeletalmuscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes 46: 920-923.
7. Patti, M.E., A.J. Butte, S. Crunkhorn, et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100: 8466-8471.
8. Kelley,D.E., J.He, E.V.Menshikova, et al. 2002. Dysfunction of mitochondria in human skeletalmuscle in type 2 diabetes. Diabetes 51: 2944-2950.
9. Petersen, K.F., S. Dufour, D. Befroy, et al. 2004. Impaired mitochondrial activity in the insulin- resistant offspring of patients with type 2 diabetes.N. Engl. J. Med. 350: 664-671.
10. Mogensen, M., K. Sahlin, M. Fernström, et al. 2007. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592-1599.
11. Choo, H.J., J.H. Kim, O.B. Kwon, et al. 2006. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49: 784-791.
12. Maechler, P. & C.B.Wollheim. 2001.Mitochondrial function in normal and diabetic beta-cells. Nature 414: 807-812.
13. Park, S.Y. & W. Lee. 2007. The depletion of cellular mitochondrial DNA causes insulin resistance through the alteration of insulin receptor substrate-1 in ratmyocytes. Diabetes Res. Clin. Pract. 77(Suppl 1): S165-S171.
14. Pravenec,M., M. Hyakukoku, J. Houstek, et al. 2007. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res. 17: 1319-1326.
15. Lim, J.H., J.I. Lee, Y.H. Suh, et al. 2006. Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells. Diabetologia 49: 1924-1936.
16. Erol, A. 2007. Insulin resistance is an evolutionarily conserved physiologicalmechanism at the cellular level for protection against increased oxidative stress. Bioessays 29: 811-818.
17. Gaster, M., A.C. Rustan, V. Aas, et al. 2004. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53: 542-548.
18. Zhang, D., Z.X. Liu, C.S. Choi, et al. 2007. Mitochondrial dysfunctiondue to long-chain acyl-CoAdehydrogenasedeficiency causes hepatic steatosis and hepatic insulin resistance. Proc. Natl. Acad. Sci. USA 104: 17075-17080.
19. Itani, S.I.,W.J. Pories,K.G.Macdonald, et al. 2001. Increased protein kinase C theta in skeletalmuscle of diabetic patients. Metabolism 50: 553-557.
20. Abel, E.D., O. Peroni, J.K. Kim, et al. 2001. Adipose-selective targeting of theGLUT4 gene impairs insulin action inmuscle and liver. Nature 409: 729-733.
21. Minamino, T., M. Orimo, I. Shimizu, et al. 2009. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15: 1082-1087.
22. Rosen, E.D. & B.M. Spiegelman. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
23. Hotta, K., T. Funahashi, Y. Arita, et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20: 1595-1599.
24. Li, K., L. Li, G.Y. Yang, et al. 2010. Effect of shRNA-mediated adiponectin/Acrp30 down-regulation on insulin signaling and glucose uptake in the 3T3-L1 adipocytes. J. Endocrinol. Invest. 33: 96-102.
25. Koh, E.H., J.Y. Park, H.S. Park, et al. 2007. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56: 2973-2981.
26. Kallenborn, R. 2006. Persistent organic pollutants (POPs) as environmental risk factors in remote high-altitude ecosystems. Ecotoxicol. Environ. Saf. 63: 100-107.
27. Lee,D.H. & D.R. Jacobs Jr. 2006. Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase: results from the National Health and Examination Survey 1999-2002. Clin.Chem. 52: 1825-1827.
28. Beard, J., T. Sladden, G. Morgan, et al. 2003. Health impacts of pesticide exposure in a cohort of outdoor workers. Environ. Health Perspect. 111: 724-730.
29. Shertzer, H.G., M.B. Genter, D. Shen, et al. 2006. TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial FoF1-ATP synthase and ubiquinone. Toxicol. Appl. Pharmacol. 217: 363-374.
30. Lim, S., S.Y. Ahn, I.C. Song, et al. 2009. Chronic exposure to the herbicide, atrazine, causesmitochondrial dysfunction and insulin resistance. PLoS One 4: e5186.
31. Wilson-Fritch, L., S. Nicoloro, M. Chouinard, et al. 2004. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114: 1281-1289.
32. Wilson-Fritch, L., A. Burkart, G. Bell, et al. 2003.Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23: 1085-1094.
33. Mensink, M., M.K. Hesselink, A.P. Russell, et al. 2007. Improved skeletalmuscle oxidative enzymeactivity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int. J. Obes. (London). 31: 1302-1310.
34. Henriksen, E.J. 2002. Invited review: effects of acute exercise and exercise training on insulin resistance. J. Appl. Physiol. 93: 788-796.
35. Lagouge, M., C. Argmann, Z. Gerhart-Hines, et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
36. Moon,H.S., H.G. Lee, Y.J. Choi, et al. 2007. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact. 167: 85-98.
37. Jacob, S., R.S. Streeper, D.L. Fogt, et al. 1996. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45: 1024-1029.
38. Yaworsky, K., R. Somwar, T. Ramlal, et al. 2000. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43: 294-303.
39. Shen,W., K. Liu, C. Tian, et al. 2008. R-alphalipoicacid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 51: 165-174.
40. Fridlyand, L.E. & L.H. Philipson. 2006. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8: 136-145.